<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Zydus Lifesciences Limited

NSE: ZYDUSLIFE · Lot size: 900

OverviewOption ChainOI AnalysisFII / DIIMax Pain

Zydus Lifesciences Limited FII & DII Activity

FII Net (₹ Cr)
-1,059.93
Buy 12,756.88 · Sell 13,816.81
DII Net (₹ Cr)
+2,966.89
Buy 18,753.06 · Sell 15,786.17
FII F&O Net (contracts)
+0
Index + stock futures

5-Day Flow Trend

DateFII Net (₹ Cr)DII Net (₹ Cr)
2026-04-21-1,059.93+2,966.89
2026-04-20+683.2-4,721.48
2026-04-18+683.2-4,721.48
AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

Foreign Institutional Investors (FIIs) sold ₹1059.93 Cr in cash, intensifying outflows as Domestic Institutional Investors (DIIs) countered with strong buying of ₹2966.89 Cr. This sharp divergence underscores DII dominance in absorbing FII selling pressure. Institutional sentiment remains split, with domestic players showing greater risk appetite.

Trend vs 5-Day Average

Today’s FII outflow is below their 5-day average inflow of ₹683.2 Cr, signaling a sudden shift from recent accumulation. Conversely, DII buying reverses their weak 5-day average of ₹-4721.48 Cr, indicating a meaningful rebound in domestic confidence.

F&O Positioning Signal

FII F&O cash stood at ₹0 Cr, reflecting no directional derivatives bets on Zydus Lifesciences Limited. However, the Index Futures Long/Short ratio of 1.2 suggests FIIs maintain overall market optimism despite sector-specific caution.

Implication for Finance

Persistent DII demand may support pharmaceutical stocks like Zydus Lifesciences Limited, potentially lifting sector sentiment in early trading tomorrow.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-04-21

Related Analysis

Same Sector

ABB
ABB India Limited
Neutral
ABCAPITAL
Aditya Birla Capital Limited
Neutral
ADANIENSOL
Adani Energy Solutions Limited
Neutral
ADANIENT
Adani Enterprises Limited
Neutral
ADANIGREEN
Adani Green Energy Limited
Neutral

Frequently Asked Questions

What is FII net buying/selling in Zydus Lifesciences Limited today?▾
FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹1,059.93 Cr (net selling) as of 2026-04-21. This market-wide figure applies to all F&O stocks including Zydus Lifesciences Limited.
What is DII activity in Zydus Lifesciences Limited today?▾
DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹2,966.89 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.
What is FII F&O net for Zydus Lifesciences Limited today?▾
FII net F&O position (index + stock futures combined) is +0 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.
Were there any block deals in Zydus Lifesciences Limited?▾
Block deal data for Zydus Lifesciences Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.
How does FII/DII data affect Zydus Lifesciences Limited stock price?▾
FII and DII flows are market-wide data — all F&O stocks including Zydus Lifesciences Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Zydus Lifesciences Limited's individual OI buildup type, this provides a directional framework.